IRVINE, Calif., May 30 /PRNewswire-FirstCall/ -- CalbaTech, Inc. , an emerging life sciences company (http://www.CalbaTech.com) concentrating on banking adult stem cells for possible future therapeutic uses and providing products and platforms to the biotech, pharmaceutical research market and to academic institutions, today announced its stem cell subsidiary LifeStem, Inc. contributed five Stem Cell Microbank(TM) services to the Los Angeles chapter of the Juvenile Diabetes Research Foundation for its third annual gala "Finding A Cure: A Love Story Benefiting Stem Cell Research" held May 24th at the Beverly Hilton Hotel in Los Angeles.
This annual event benefits stem cell research with the potential to cure diabetes, plus other life threatening diseases including Alzheimer's, Parkinson's disease and Multiple Sclerosis. Country music star Garth Brooks was honored with the Angel Award along with Steve and Ann Radar who received the Caregiver Award. Country music singing star Trisha Yearwood was also in attendance. Previous award recipients at "Finding A Cure" include Nancy Reagan, James Taylor, Robin Williams, Michael J. Fox and Dana Reeve.
"We are delighted to have been part of this event and to contribute to its success. Our subsidiary, LifeStem, which is overseeing the MicroBank(TM) Service, is the only company to collect and store adult stem cells from two different cell sources for possible future therapeutic uses," said CalbaTech CEO James DeOlden. "Someday we will look back on events like this and realize the importance of this early work on stem cell research in conquering some of mankind's most difficult diseases. With the research efforts by organizations such as JDRF to find cures through the use of stem cells, our Stem Cell Microbank(TM) Service may provide the vehicle for people who bank their stem to take advantage of such cures. We obviously believe that our Stem Cell Microbank(TM) Service complements the research efforts of JDRF, and others, and we applaud their tireless efforts."
About CalbaTech
CalbaTech, Inc. is an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.
About LifeStem
LifeStem, a wholly owned subsidiary of CalbaTech, is focused on services and technologies to facilitate the collection of adult stem cells, development of stem cell delivery devices for clinical applications and clinical applications of specific stem cell based therapies. LifeStem, in addition to being the first company to offer micro collection of stem cells, is also the first company to offer a collection service that collects and stores two different types of stem cells. The Company has filed patent applications for an endoscopic stem cell delivery device and its novel Stem Cell MicroBank(TM) service.
Contact: Paul Knopick E&E Communications (949) 707-5365 pknopick@eandecommunications.com
Note: Certain statements in this news release may contain "forward-looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. We use words such as "anticipate," "believe," "expect," "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to being in a large and growing market, exhibiting rapid growth characteristics, and having a growth strategy, are forward looking statements. These forward looking statements are only predictions and are subject to certain risks, uncertainties and assumptions. Some of the risks, uncertainties and assumptions that could cause actual results to differ materially from estimates or assumptions in this press release include the risk that we will not be able to grow our revenues and market share, the risk that our prices do not remain competitive and the risk that we will not achieve profitability. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission, including our most recent Report on Form 10-KSB, and Reports on Form 10-QSB and Form 8-K. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims, any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.
CalbaTech, Inc.CONTACT: Paul Knopick of E&E Communications, +1-949-707-5365,pknopick@eandecommunications.com, for CalbaTech, Inc.
Web site: http://www.CalbaTech.com/
